title: Haemopoietic reconstitution after autologous blood stem cell transplantation in patients with malignancies: a multicentre retrospective study.
abstract: A retrospective study was undertaken to evaluate the efficacy of autologous blood stem cell transplantation (ABSCT) in terms of haemopoietic reconstitution after ablative chemotherapy or chemo-radiotherapy. 55 patients with malignancies, observed in four Italian institutions from January 1987 to June 1991, were eligible for evaluation. This series included 19 non-Hodgkin's lymphoma, 11 multiple myeloma, nine ovarian cancer, seven Hodgkin's disease, seven non-lymphocytic leukaemia, one acute lymphoblastic leukaemia, one neuroblastoma. 522 PBSC collections were performed on 55 patients. Following ABSCT, the rate of engraftment was positively related to the dose of CFU-GM infused and negatively to the presence of bone marrow involvement at conditioning. 48 patients out of 55 transplanted (87%) had rapid, complete and sustained engraftment. Three patients (5%) died of transplant-related complications. Considering that 60% of the patients in this series were in partial remission or in progressive disease at the time of ABSCT, we conclude that ABSCT is a safe approach for the use of ablative conditioning therapy in patients with a wide scope of malignancies, provided that a large number of CFU-GM have been collected after mobilizing treatment.
authors.affiliation: Servizio di Ematologia ed Emotransfusione, Universitá Cattolica del Sacro Cuore, Roma, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Pierelli
authors.forename: A
authors.initials: A
authors.lastname: Iacone
authors.forename: A M
authors.initials: AM
authors.lastname: Quaglietta
authors.forename: A
authors.initials: A
authors.lastname: Nicolucci
authors.forename: G
authors.initials: G
authors.lastname: Menichella
authors.forename: P
authors.initials: P
authors.lastname: Benedetti Panici
authors.forename: D
authors.initials: D
authors.lastname: D'Antonio
authors.forename: A
authors.initials: A
authors.lastname: De Laurenzi
authors.forename: L
authors.initials: L
authors.lastname: De Rosa
authors.forename: G
authors.initials: G
authors.lastname: Fioritoni
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001772:Blood Cell Count; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006085:Graft Survival; D006410:Hematopoiesis; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy / Q000628:therapy*; D012189:Retrospective Studies; D014182:Transplantation, Autologous; D016896:Treatment Outcome